Tyers Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Tyers Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$21K	Buy	656 +448	+215%	+$18.5K	﹤0.01%	946
2019 Q2	$10K	Sell	208 -2,928	-93%	-$156K	﹤0.01%	979
2019 Q1	$212K	Buy	3,136 +928	+42%	+$54.1K	0.01%	697
2018 Q4	$102K	Buy	2,208 +2,096	+1,871%	+$129K	﹤0.01%	805
2018 Q3	$9K	Sell	112 -208	-65%	-$16.7K	﹤0.01%	966
2018 Q2	$27K	Buy	320 +288	+900%	+$25.1K	﹤0.01%	941
2018 Q1	$3K	Buy	+32	New	+$2.47K	﹤0.01%	970

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Tyers Asset Management's AGIO Position: Q3 2019 in Review

Tyers Asset Management increased its Agios Pharmaceuticals (AGIO) stake by 215% in Q3 2019, buying an estimated $18.5K and bringing the position to 656 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #946.

Tyers Asset Management first reported a position in AGIO in Q1 2018 and has held it in 7 quarters since. The position peaked at $212K in Q1 2019. 189 funds tracked by Wall St. Rank hold AGIO as of Q3 2019.

Tyers Asset Management held 656 shares of Agios Pharmaceuticals worth $21K as of Q3 2019.
Tyers Asset Management bought 448 Agios Pharmaceuticals shares in Q3 2019, an estimated $18.5K.
Agios Pharmaceuticals made up ﹤0.01% of Tyers Asset Management's portfolio in Q3 2019, its #946 holding.
Tyers Asset Management first reported a position in Agios Pharmaceuticals in Q1 2018 and has held it in 7 quarters since.
Tyers Asset Management's Agios Pharmaceuticals position peaked at $212K in Q1 2019.
189 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.